A Study to Evaluate the Safety and Effectiveness of Mirodenafil in Korean Patients With Erectile Dysfunction
NCT ID: NCT01802359
Last Updated: 2017-06-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
379 participants
OBSERVATIONAL
2011-11-07
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial to Evaluate the Efficacy and Safety of HCP1302
NCT02587988
Effect of Tadalafil on Erectile Dysfunction Treatment and QOL Improvement Effect (by SF-12) in Andropause Patients With Erectile Dysfunction
NCT02943356
Safety and Efficacy of YHD1023 in Erectile Dysfunction
NCT01423370
A Study of DA-8159 in Subjects With Erectile Dysfunction
NCT00282607
Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and Hypertension
NCT00644007
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mirodenafil
No intervention
This is an observational study. Korean male participants receiving mirodenafil as per the prescribing information will be observed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
This is an observational study. Korean male participants receiving mirodenafil as per the prescribing information will be observed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants prescribed mirodenafil on demand
Exclusion Criteria
19 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Janssen Korea, Ltd., Korea
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Janssen Korea, Ltd., Korea Clinical Trial
Role: STUDY_DIRECTOR
Janssen Korea, Ltd., Korea
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MIRODENEDY4002
Identifier Type: OTHER
Identifier Source: secondary_id
MIR-KOR-PMS
Identifier Type: OTHER
Identifier Source: secondary_id
CR100836
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.